Skip to content

Persistent Weight Loss with a Non-invasive Novel Medical Device In Obese Individuals With High-risk Cardiovascular Risk Profile

Persistent Weight Loss with a Non-invasive Novel Medical Device In Obese Individuals With High-risk Cardiovascular Risk Profile

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00011357
Enrollment
6
Registered
2016-12-08
Start date
2015-07-02
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E66.9

Interventions

Group 1: Patients with overweight and obesity and increased cardiovascular risk profil were provided the medical device in an one-armed observational study and interrogated with standardised questionn

Sponsors

Praxis
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18 to 95 years 2. Gender: male + female 3. Capacity to consent 4. Signed consent form 5. Failure of a basic program (nutritional, exercise and behavioural therapy) 6. Received medical device 7. at least 2 documented visits after receiving the medical device

Exclusion criteria

Exclusion criteria: 1. Weight reduction > 5% over the last months before inclusion into the study 2. Wasting disease 3. Medication influeincing weight loss 4. Pregnancy or breastfeeding women 5. Mental disorders or non-compliance 6. Incapacity to give informed consent 7. Participation in another therapy program or study 8. Exclsuion by dentist for dental of maxillary joint problems

Design outcomes

Primary

MeasureTime frame
PEP is efficiency (weight reduction) of the medical device.

Secondary

MeasureTime frame
The security of the medical device will be controlled through regular visits and participants have been advised to present immediately if problems occur. Anthropometric measurements will be done and they will be asked to complete two questionnaires during usage of the medical device. Furthermore participants will be followed up through telephone contacts. Detailed informations about the medical device will be given in a separate information brochure. The mode of action will be assessed through questionnaires at the beginning and end of usage of the medical device.

Countries

Germany

Contacts

Public ContactCaroline Schmidt-Lucke

MEDIACC, Medico-academic Consultings

info@mediacc.org03052104480

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 27, 2026